T5 Helix Advisory partners with biotech companies and CDMOs on high-value, complex commercial situations where technical execution directly impacts deal outcomes, timelines, and growth.
We operate at the intersection of commercial strategy, CMC, regulatory, and manufacturing—aligning technical and commercial priorities to enable successful transactions and scalable growth.
Strategic transactions and CDMO partnerships
Structuring and executing complex agreements where technical, commercial, and regulatory considerations must align
Commercial strategy and growth acceleration
Aligning pipeline, positioning, and partnership strategy to drive near- and long-term revenue outcomes
CMC, regulatory, and manufacturing integration
Bridging technical and commercial functions to enable efficient execution and reduce downstream risk
Tech transfer and commercialization readiness
Supporting the transition from development to scalable manufacturing and commercial supply
T5 Helix Advisory engages selectively in high-impact situations where commercial strategy, technical execution, and deal structure must align.
Typical engagement formats include:
Strategic Transaction Support
Advising on CDMO selection, structuring, and execution of complex partnerships, including MSAs, supply agreements, and long-term collaborations
Commercial Strategy & Growth Advisory
Supporting leadership teams on market positioning, partnership strategy, and pipeline development to drive near- and long-term growth
Interim & Executive-Level Support
Operating alongside leadership teams during periods of transition, scaling, or strategic inflection, including board-facing roles
Global commercial leadership experience with over two decades in biopharma, operating at the intersection of CDMO strategy, strategic partnerships, and complex deal execution.
Our experience includes:
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.